Table 1.
Age | Mean | 64.4 (±11.9) |
Gender | Male | 78 (79%) |
Female | 20 (21%) | |
Event | Relapse | 45 (46%) |
Non-relapse | 53 (54%) | |
Follow-up [months] | Mean | 15.7 (±14.6) |
Stage [previously resected tumor] | Papilloma | 4 |
Tis | 2 | |
Ta | 74 | |
T1 | 10 | |
T2 | 2 | |
T3 | 1 | |
Tx | 5 | |
Grade [previously resected tumor] | G1 | 22 |
G2 | 48 | |
G3 | 17 | |
Gx | 2 | |
Unknown | 9 | |
Multiplicity [previously resected tumor] | Solitary | 51 |
Multiple | 37 | |
Unknown | 10 |
No significant differences were detected with regards to age, gender, and number of events between the training and the test set.